A
AtriCure, Inc.
ATRC · NASDAQ · Healthcare · 2.3B
Price · close
$48.98
+3.14% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.8×
Enterprise value / EBITDAEV/EBITDA
139.1×
Free cash flow yieldFCF yield
2.1%
Return on equityROE
-2.3%
Operating margin
-0.6%
Net debt / EBITDAbalance-sheet strength
-4.9×
Interest coverage
-0.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.